Results 131 to 140 of about 2,924 (161)

Botulinum Toxin Treatment for Spasmodic Dysphonia

Acta Oto-Laryngologica, 1993
Effective treatment of adductor type spasmodic dysphonia with botulinum toxin injection is presented. Patients showed objective and/or subjective improvement in phonation. The beneficial effect lasted for approximately 3 months. An immediate complication is temporary hoarseness or aphonia, mainly due to diffusion of BT into the adjacent muscles.
Masanobu Kumada, Hiroko Kosaki, Hajime Hirose, Seiji Niimi, Takeo Kobayashi   +4 more
openaire   +3 more sources

Laryngeal Sensory Symptoms in Spasmodic Dysphonia

Journal of Voice, 2023
The purpose of this research was to determine whether an association between laryngeal hypersensitivity (LH) and spasmodic dysphonia (SD) exists using the LH Questionnaire (LHQ). This study also explored the prevalence of self-reported upper respiratory infection (URI) at the time of SD onset across SD phenotypes.Individuals with and without SD were ...
Victoria Vanderaa, Lisa A. Vinney
openaire   +3 more sources

Contemporary management of spasmodic dysphonia

Current Opinion in Otolaryngology & Head and Neck Surgery, 2004
To review current concept in spasmodic dysphonia management.The standard of care for spasmodic dysphonia in 2004 remains botulinum toxin chemodenervation for symptomatic management. This is supported by a large body of literature attesting to its efficacy in many different hands, particularly for the adductor form of the disorder.
openaire   +3 more sources

Spasmodic Dysphonia and Vocal Tremor

2021
Spasmodic dysphonia is a focal laryngeal dystonia affecting the voice. Several subtypes exist, presenting different diagnostic and treatment challenges. Vocal tremor is a separate disorder characterized by involuntary oscillation of the laryngeal and pharyngeal musculature, resulting in modulation of pitch and loudness.
Andrew Blitzer, Diana N. Kirke
openaire   +2 more sources

Behavioral therapy for spasmodic dysphonia

Journal of Voice, 1992
Summary This paper presents a general schema for classifying treatment approaches for both functional and organic voice disorders. It's use is illustrated by a review of treatments for Spasmodic Dysphonia. Most behavioral approaches have been found to be unsuccessful except for mild cases.
openaire   +2 more sources

Spasmodic Dysphonia: Current Therapies

Otolaryngology–Head and Neck Surgery, 1995
Educational objectives: To identify patients with adductor and abductor spasmodic dysphonia and to understand and organize a comprehensive management program, including diagnosis and current treatment of patients with spasmodic dysphonia.
Gayle E. Woodson, Thomas Murry
openaire   +2 more sources

Spasmodic Dysphonia Subsequent to Head Trauma

Archives of Otolaryngology - Head and Neck Surgery, 1987
Spasmodic dysphonia (SD) is a low-incidence voice disorder of unknown origin. A subgroup of seven patients with SD from our larger pool of 70 report vocal symptoms subsequent to head injury. This article is a case report of the neurodiagnostic findings, including computed tomography, magnetic resonance imaging, auditory brain-stem response, brain ...
Frances J. Freeman, Steven D. Schaefer, Michael P. Cannito, Terese Finitzo, Elliott D. Ross, Kenneth D. Pool, Michael D. Devous   +6 more
openaire   +3 more sources

Perceptual-acoustic relationships in spasmodic dysphonia

Journal of Voice, 1993
Perceptual ratings were obtained from voice samples of 19 patients with adductor spasmodic dysphonia before and 1 week after unilateral treatment with Botulinum toxin. Five experienced listeners judged samples of sustained phonation using a seven-point equal-interval scale.
Thomas Murry, Thomas Murry, Thomas Murry, Gayle E. Woodson, Petra Zwirner   +4 more
openaire   +3 more sources

Botulinum Toxin for Relief of Spasmodic Dysphonia

Archives of Otolaryngology - Head and Neck Surgery, 1987
To the Editor .—The preliminary report by Miller and coworkers, 1 and two other presentations at our national meetings, have demonstrated the temporary effectiveness of botulinum toxin (BT) for the relief of spasmodic dysphonia. The use of a myoneural blocking agent such as BT is logical, and has the advantage that different adductor muscles can be ...
openaire   +3 more sources

BOTULINUM TOXIN FOR THE TREATMENT OF SPASMODIC DYSPHONIA

Otolaryngologic Clinics of North America, 2000
Spasmodic dysphonia is a focal laryngeal dystonia. Laryngeal dystonia presents as: adductor spasmodic dysphonia with the characteristic strain-strangle voice; abductor spasmodic dysphonia with hypophonia and breathy breaks in connected speech; and adductor respiratory dystonia with paradoxical vocal fold motion and intermittent stridor.
Scott R. Gibbs, Andrew Blitzer
openaire   +3 more sources